Skip to main content
Jeffrey Towbin, MD, Pediatric Cardiology, Memphis, TN, University of Tennessee Health Science Center

JeffreyTowbinMD

Pediatric Cardiology • Memphis, TN

Pediatric Cardiac Genetics, Pediatric Heart Failure and Heart Transplantation

Executive Co-Director, The Heart Institute, Le Bonheur Children's Hospital, Professor & Chief, Pediatric Cardiology, Le Bonheur Children's Hospital, St. Jude Children's Research Hospital, and University of Tennessee Health Science Center, and Vice Chair of Pediatrics for Strategy Advancement

Join to view full profile

Dr. Towbin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Towbin's full profile

Already have an account?

Summary

  • Jeffrey A. Towbin, M.D., is the Executive Co-Director of the Heart Institute and Chief of Pediatric Cardiology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center in Memphis. He is the Medical Director of the Cardiomyopathy, Heart Failure, and Transplant Services and is interested in the clinical, genetic and mechanistic aspects of cardiomyopathies, arrhythmias, and causes of sudden cardiac death.

    Dr. Towbin's research has focused on cardiovascular gene identification, animal and cellular models of human cardiomyopathies and arrhythmias, as well as acquired forms of heart muscle disease including myocarditis, post-transplant cardiac rejection, and etiology and mechanisms of cardiotoxicity (cardio-oncology). Studies published to date has generated new knowledge, which is allowing clarification of underlying pathophysiology, which then guides targeted treatment options.

    Current Focus areas
    Arrhythmogenic cardiomyopathy. Dr. Towbin's research in arrhythmogenic cardiomyopathy has explored and identified genes responsible for the phenotypes of this group of patients, mechanisms responsible for the development and progression of disease, including modifier genes as well as the effects of increased mechanical stress on the heart. He authored the most recent expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy (2019).
    Left ventricular noncompaction cardiomyopathy. Dr. Towbin has published data on clinical phenotyping/diagnosis of left ventricular noncompaction cardiomyopathy, risk stratification in left ventricular noncompaction cardiomyopathy, clinical presentation and disease progression. He is also involved in ongoing genetic research with regards to patient gene identification and mechanism determination using animal models.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Cardiology, 1985 - 1989
  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1982 - 1985
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1982

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1987 - 2024
  • TN State Medical License
    TN State Medical License 2015 - 2024
  • OH State Medical License
    OH State Medical License 1983 - 2021
  • American Board of Pediatrics Pediatric Cardiology

Awards, Honors, & Recognition

  • Distinguished Scientist of the American Heart Association Award American Heart Association, 2017
  • Fellow (FAHA) American Heart Association
  • American Heart Association Basic Research Prize American Heart Association, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of Left Ventricular hypertrabeculation/noncompaction Among Children with Sickle Cell Disease  
    Jeffrey Towbin, MD, Congenital Heart Disease

Press Mentions

  • Vigorous Physical Activity and Left Ventricular Noncompaction
    Vigorous Physical Activity and Left Ventricular NoncompactionOctober 7th, 2020
  • 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines
    2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice GuidelinesMarch 2nd, 2019
  • When Exercise Is Unhealthy for the Heart: How Heart Problems and Sudden Cardiac Death Occur with Endurance Exercise
    When Exercise Is Unhealthy for the Heart: How Heart Problems and Sudden Cardiac Death Occur with Endurance ExerciseNovember 24th, 2015
  • Join now to see all

Grant Support

  • Discovery of modifier genes in cardiomyopathyNIH-NHLBI2020–2024

Professional Memberships

Hospital Affiliations

Dr. Jeffrey Towbin, Dr. Jeffrey Towbin, MD, Dr. J Towbin